Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11260030B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jun 10, 2021 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Jun 10, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2086
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral tablet for delivery of active ingredients to the gastrointestinal tract includes a population of particles and an active ingredient to be delivered to the gastrointestinal tract. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the gastrointestinal tract as part of the saliva generated upon mastication of the tablet.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.